SB557 (2026) Compare Changes


The Bill Text indicates a new section is being inserted. This situation is not handled right now, and the new text is displayed in both the changed and unchanged versions.

Unchanged Version

Text to be removed highlighted in red.

1 New Subdivision; Synthetic Kratom Policy. Amend RSA 318-B by inserting after section 50 the following new subdivision:

Synthetic Kratom Policy

318-B:51 Definitions. In this subdivision, "synthetic kratom" or "semisynthetic kratom" means:

I. An alkaloid or alkaloid derivative that has been created by chemical synthesis or biosynthetic means, including fermentation, recombinant techniques, yeast derived, and enzymatic techniques, rather than traditional food preparation techniques, such as heating or extracting that synthetically alters the composition of any kratom alkaloid or constituent; or

II. An alkaloid or alkaloid derivative contained in kratom that has been exposed to chemicals or processes that would confer a structural change in the alkaloids, resulting in material that has been chemically altered.

318-B:52 Synthetic Kratom Limitations. No person or entity person shall prepare, distribute, manufacture, sell, possess, or advertise synthetic or semisynthetic kratom, unless such preparation, distribution, manufacturing, sale, possession, or advertisement is undertaken for the sole purpose of scientific research.

2 New Paragraph; Controlled Drug Act; Scheduling by the Commissioner. Amend RSA 318-B:1-a by inserting after paragraph VIII the following new paragraph:

IX. Notwithstanding paragraph I, synthetic or semisynthetic kratom shall be classified as a schedule II controlled drug.

3 Effective Date. This act shall take effect upon its passage.

Changed Version

Text to be added highlighted in green.

1 New Subdivision; Synthetic Kratom Policy. Amend RSA 318-B by inserting after section 50 the following new subdivision:

Synthetic Kratom Policy

318-B:51 Definitions. In this subdivision, "synthetic kratom" or "semisynthetic kratom" means:

I. An alkaloid or alkaloid derivative that has been created by chemical synthesis or biosynthetic means, including fermentation, recombinant techniques, yeast derived, and enzymatic techniques, rather than traditional food preparation techniques, such as heating or extracting that synthetically alters the composition of any kratom alkaloid or constituent; or

II. An alkaloid or alkaloid derivative contained in kratom that has been exposed to chemicals or processes that would confer a structural change in the alkaloids, resulting in material that has been chemically altered.

318-B:52 Synthetic Kratom Limitations. No person or entity person shall prepare, distribute, manufacture, sell, possess, or advertise synthetic or semisynthetic kratom, unless such preparation, distribution, manufacturing, sale, possession, or advertisement is undertaken for the sole purpose of scientific research.

2 New Paragraph; Controlled Drug Act; Scheduling by the Commissioner. Amend RSA 318-B:1-a by inserting after paragraph VIII the following new paragraph:

IX. Notwithstanding paragraph I, synthetic or semisynthetic kratom shall be classified as a schedule II controlled drug.

3 Effective Date. This act shall take effect upon its passage.